| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
143,520,000 |
| Market
Cap: |
63.51(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4425 - $0.4425 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile EyePoint Pharmaceuticals is a pharmaceutical company focused on developing and commercializing therapeutics for patients with eye disorders. Co.'s primary product candidate, EYP-19, is a potential sustained delivery intravitreal anti-VEGF treatment targeting wet age-related macular degeneration. YUTIQ 50 (fluocinolone acetonide intravitreal implant) 0.18 mg for intravitreal injection, is for the treatment of non-infectious uveitis affecting the posterior segment of the eye. DEXYCU® (dexamethasone intraocular suspension) 9%, for intraocular administration, is indicated for the treatment of post-operative ocular inflammation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
1,431,765 |
4,794,057 |
4,794,057 |
4,794,057 |
| Total Buy Value |
$20,571,167 |
$89,496,413 |
$89,496,413 |
$89,496,413 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
2 |
6 |
6 |
6 |
| Total Shares Sold |
0 |
6,161,499 |
6,722,029 |
6,722,029 |
| Total Sell Value |
$0 |
$121,266,413 |
$128,353,600 |
$128,353,600 |
| Total People Sold |
0 |
6 |
7 |
7 |
| Total Sell Transactions |
0 |
24 |
32 |
32 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ashton Paul |
President & CEO |
• • – |
2014-08-01 |
4 |
OE |
$1.13 |
$11,300 |
D/D |
10,000 |
450,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-07-01 |
4 |
AS |
$4.32 |
$43,200 |
D/D |
(10,000) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-07-01 |
4 |
OE |
$1.13 |
$11,300 |
D/D |
10,000 |
450,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-19 |
4 |
AS |
$4.00 |
$12,276 |
D/D |
(3,069) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-19 |
4 |
OE |
$1.13 |
$3,468 |
D/D |
3,069 |
443,810 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-18 |
4 |
AS |
$4.00 |
$15,724 |
D/D |
(3,931) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-18 |
4 |
OE |
$1.13 |
$4,442 |
D/D |
3,931 |
444,672 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-17 |
4 |
AS |
$4.00 |
$17,856 |
D/D |
(4,464) |
96,423 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-17 |
4 |
OE |
$1.81 |
$8,080 |
D/D |
4,464 |
100,887 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-17 |
4 |
AS |
$4.00 |
$18,000 |
D/D |
(4,500) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-17 |
4 |
OE |
$1.13 |
$5,085 |
D/D |
4,500 |
445,241 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-16 |
4 |
AS |
$4.01 |
$13,778 |
D/D |
(3,436) |
96,423 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-16 |
4 |
OE |
$1.81 |
$6,219 |
D/D |
3,436 |
99,859 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-16 |
4 |
AS |
$4.01 |
$12,832 |
D/D |
(3,200) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-16 |
4 |
OE |
$1.13 |
$3,616 |
D/D |
3,200 |
443,941 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-13 |
4 |
AS |
$4.01 |
$8,421 |
D/D |
(2,100) |
96,423 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-13 |
4 |
OE |
$1.81 |
$3,801 |
D/D |
2,100 |
98,523 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-13 |
4 |
AS |
$4.01 |
$8,822 |
D/D |
(2,200) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-13 |
4 |
OE |
$1.13 |
$2,486 |
D/D |
2,200 |
442,941 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-12 |
4 |
AS |
$4.02 |
$38,592 |
D/D |
(9,600) |
96,423 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-12 |
4 |
OE |
$1.81 |
$17,376 |
D/D |
9,600 |
106,023 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-12 |
4 |
AS |
$4.02 |
$38,592 |
D/D |
(9,600) |
440,741 |
|
- |
|
| Ashton Paul |
President & CEO |
• • – |
2014-06-12 |
4 |
OE |
$1.13 |
$10,848 |
D/D |
9,600 |
450,341 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-05-05 |
4 |
AS |
$4.01 |
$14,035 |
D/D |
(3,500) |
96,423 |
|
- |
|
| Freedman Lori |
VP Corp. Affairs, GC and Sec |
• – – |
2014-05-05 |
4 |
OE |
$1.81 |
$6,335 |
D/D |
3,500 |
99,923 |
|
- |
|
252 Records found
|
|
Page 10 of 11 |
|
|
